Shanghai Shyndec Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Shanghai Shyndec Pharmaceutical Co Ltd cash flow-to-debt ratio. Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Cash Flow-to-Debt Ratio of 0.13x as of September 2025, meaning its operating cash flow of CN¥486.04 Million could theoretically repay 0% of its total liabilities (CN¥3.63 Billion) in one year. Check 600420 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shanghai Shyndec Pharmaceutical Co Ltd (2004–2024)
Cash flow-to-debt ratio of Shanghai Shyndec Pharmaceutical Co Ltd from 2004 to 2024. Historical debt coverage capacity for Shanghai Shyndec Pharmaceutical Co Ltd across 21 annual periods. Check 600420 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Shanghai Shyndec Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2004–2024)
Shanghai Shyndec Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2004 to 2024. Year-by-year debt coverage analysis for Shanghai Shyndec Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 600420 cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.49x | CN¥2.26 Billion | CN¥4.63 Billion | ▲ +41.9% |
| 2023 | 0.34x | CN¥1.72 Billion | CN¥5.01 Billion | ▼ -10.2% |
| 2022 | 0.38x | CN¥2.86 Billion | CN¥7.48 Billion | ▲ +97.8% |
| 2021 | 0.19x | CN¥1.68 Billion | CN¥8.70 Billion | ▲ +4.3% |
| 2020 | 0.19x | CN¥1.56 Billion | CN¥8.43 Billion | ▲ +22.9% |
| 2019 | 0.15x | CN¥1.27 Billion | CN¥8.44 Billion | ▼ -27.6% |
| 2018 | 0.21x | CN¥1.67 Billion | CN¥8.02 Billion | ▼ -32.4% |
| 2017 | 0.31x | CN¥2.31 Billion | CN¥7.52 Billion | ▲ +196.3% |
| 2016 | 0.10x | CN¥838.58 Million | CN¥8.08 Billion | ▲ +15.7% |
| 2015 | 0.09x | CN¥226.65 Million | CN¥2.53 Billion | ▼ -16.1% |
| 2014 | 0.11x | CN¥258.51 Million | CN¥2.42 Billion | ▼ -6.2% |
| 2013 | 0.11x | CN¥207.50 Million | CN¥1.82 Billion | ▼ -24.7% |
| 2012 | 0.15x | CN¥193.41 Million | CN¥1.28 Billion | ▼ -39.5% |
| 2011 | 0.25x | CN¥136.12 Million | CN¥544.70 Million | ▼ -35.3% |
| 2010 | 0.39x | CN¥115.11 Million | CN¥298.05 Million | ▼ -15.1% |
| 2009 | 0.45x | CN¥97.43 Million | CN¥214.24 Million | ▲ +28.0% |
| 2008 | 0.36x | CN¥58.04 Million | CN¥163.41 Million | ▼ -48.4% |
| 2007 | 0.69x | CN¥82.31 Million | CN¥119.57 Million | ▼ -19.4% |
| 2006 | 0.85x | CN¥73.60 Million | CN¥86.15 Million | ▲ +57.4% |
| 2005 | 0.54x | CN¥57.90 Million | CN¥106.67 Million | ▲ +137.0% |
| 2004 | 0.23x | CN¥17.02 Million | CN¥74.32 Million | — |